All In Biotech

Drug Trial Radar · NCT03333200

Longitudinal Study of Neurodegenerative Disorders

Last checked: Nov 20, 2026Latest source record: Feb 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

1,500

Planned (sponsor's estimate)

Start

Jan 11, 2012

Primary completion

Jan 2030

Study completion Jan 2035

Sponsor

Lead sponsor
University of PittsburghAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 6, 2017

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
No
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to understand the course of rare genetic disorders that affect the brain. This data is being analyzed to gain a better understanding of the progression of the rare neurodegenerative disorders and the effects of interventions.

Conditions

  • MLD
  • Krabbe Disease
  • ALD
  • MPS I
  • MPS II
  • MPS III
  • Vanishing White Matter Disease
  • GM3 Gangliosidosis
  • PKAN
  • Tay-Sachs Disease
  • NP Deficiency
  • Osteopetrosis
  • Alpha-Mannosidosis
  • Sandhoff Disease
  • Niemann-Pick Diseases
  • MPS IV
  • Gaucher Disease
  • GAN
  • GM1 Gangliosidoses
  • Morquio Disease
  • S-Adenosylhomocysteine Hydrolase Deficiency
  • Batten Disease
  • Pelizaeus-Merzbacher Disease
  • Leukodystrophy
  • Lysosomal Storage Diseases
  • Purine Nucleoside Phosphorylase Deficiency
  • Multiple Sulfatase Deficiency Disease

Interventions

  • Palliative CareOther

    Collecting information about the natural progression of these diseases

  • Hematopoetic Stem Cell TransplantationBiological

    Following patients who have received HSCT as part of their clinical care.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cognitive developmentTime frame: 15 years
  2. Language developmentTime frame: 15 years
  3. Gross Motor development .Time frame: 15 years
  4. Fine Motor developmentTime frame: 15 years
  5. Adaptive living skillsTime frame: 15 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.